C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/11/2004	WO2004097023A1 Plants with pathogen resistance
11/11/2004	WO2004097016A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby
11/11/2004	WO2004096994A2 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004	WO2004096993A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	WO2004096992A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/11/2004	WO2004096990A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	WO2004096977A2 Crystal structure of homo sapiens adipocyte lipid binding protein and uses thereof
11/11/2004	WO2004096976A2 Spex compositions and methods of use
11/11/2004	WO2004096861A1 Method for modifying the size and/or morphology of starch granules
11/11/2004	WO2004096858A1 Fusion polypeptide suitable as a cytotoxin
11/11/2004	WO2004096857A2 Crystals of cytochrome p450 2c9, structures thereof and their use
11/11/2004	WO2004096856A2 Secreted protein family
11/11/2004	WO2004096854A2 Insulin analogs having protracted time action
11/11/2004	WO2004096853A1 Combined use of keratinocyte growth factor agonists and gastrin compounds
11/11/2004	WO2004096852A1 A RECOMBINANT HUMAN INTERFERON ϖ, THE METHOD FOR EXPRESSING IT AND THE USES OF IT
11/11/2004	WO2004096851A1 Galectin 9-inducing factor
11/11/2004	WO2004096850A1 Method for the production of an n-terminally modified chemotactic factor
11/11/2004	WO2004096849A2 Peptide-based cytokine/chemokine vaccines against allergy
11/11/2004	WO2004096848A2 Novel composition and methods for the treatment of immune disorders
11/11/2004	WO2004096847A1 Diagnostic importin-a having an inactivated self-inhibiting domain
11/11/2004	WO2004096846A2 Nogo-b, a regulator of endothelial cell function and vessel remodeling
11/11/2004	WO2004096845A2 Beta-amyloid inhibitors and use thereof
11/11/2004	WO2004096844A2 Group 1 mite polypeptide variants
11/11/2004	WO2004096842A2 Sars virus nucleotide and amino acid sequences and uses thereof
11/11/2004	WO2004096841A1 Glut-1 as a receptor for htlv envelopes and its uses
11/11/2004	WO2004096838A1 Template-fixed peptidomimetics as medicaments against hiv and cancer
11/11/2004	WO2004096837A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same
11/11/2004	WO2004096835A1 Nematode pppt-like sequences
11/11/2004	WO2004096834A1 Extraction process for a pharmaceutical product
11/11/2004	WO2004096832A2 Novel antiangiogenic peptides
11/11/2004	WO2004096827A2 Plant retroelements and methods related thereto
11/11/2004	WO2004096288A2 Method of obtaining dna replication minicircles which are intended to be used for gene transfer or as immunomodulators
11/11/2004	WO2004096272A2 Methods and compositions for modulating the interaction between adiponectin and its receptor
11/11/2004	WO2004096264A1 Method for treating infection with feline leukemia virus
11/11/2004	WO2004096254A2 Transferrin conjugates for tumor treatment
11/11/2004	WO2004096161A2 Pharmaceutical compositions for treating painful neuropathy and methods of treating same
11/11/2004	WO2004096160A2 Vesicle-associated proteins
11/11/2004	WO2004096136A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004087896A3 Hepatocyte differentiation of stem cells
11/11/2004	WO2004085464A3 Ph-dependent polypeptide aggregation and its use
11/11/2004	WO2004084831A3 Optimized expression of hpv 31 l1 in yeast
11/11/2004	WO2004081515A3 Purification process for bacterial cytolysin
11/11/2004	WO2004079332A3 Composition and method for increasing efficiency of introduction of target substance into cell
11/11/2004	WO2004071517A3 Uses of il-23 related reagents
11/11/2004	WO2004069863A3 Constrained hiv v3 loop peptides as immunogens and receptor antagonists
11/11/2004	WO2004068139A3 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
11/11/2004	WO2004065554A3 Human saa3 nucleic acid molecule, protein, and methods of use for same
11/11/2004	WO2004063349A3 Lysozyme transgenic ungulates
11/11/2004	WO2004058801A3 Modified vaccinia ankara expressing p53 in cancer immunotherapy
11/11/2004	WO2004056385A3 Modulation of activity of neurotrophins
11/11/2004	WO2004054508A3 Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments
11/11/2004	WO2004048410A3 T-cell receptors
11/11/2004	WO2004046183A3 Identification of an agonist-v1r receptor pair functional in the olfactory system and uses thereof
11/11/2004	WO2004039400A3 Bhv5 mutants
11/11/2004	WO2004035783A3 Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway
11/11/2004	WO2004026907A3 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
11/11/2004	WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004	WO2004020582A3 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
11/11/2004	WO2004020404A3 Modified transferin-antibody fusion proteins
11/11/2004	WO2004016810A3 Use of an mrp4 binding substances for the diagnosis and treatment of cancer
11/11/2004	WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen
11/11/2004	WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004	WO2004009775A3 Methods and compositions relating to chimeric nicotinic receptor subunits
11/11/2004	WO2004009770A3 Methods and compositions for modulating agonist-induced downregulation of g protein-coupled receptors
11/11/2004	WO2003104410A3 Enzymes
11/11/2004	WO2003102166A8 Novel flavivirus antigens
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003088916A3 Compositions and methods for the acceleration of protein secretion dynamics
11/11/2004	WO2003084988A3 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
11/11/2004	WO2003076645A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/11/2004	WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003051285A3 Therapeutic anti-hiv (iv9) compounds
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004	WO2003040695A3 Protein knobs
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein
11/11/2004	WO2003016480A3 Tgf-$g(a) polypeptides, functional fragments and methods of use therefor
11/11/2004	WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes
11/11/2004	WO2002096350A3 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
11/11/2004	WO2002083070A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
11/11/2004	WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004	WO2002031117A3 Clasp-2 transmembrane proteins
11/11/2004	US20040226054 Monitoring effectiveness of anti-alzheimer agents via measurement of adjustments in synaptophysin gene expression; tissue engineering
11/11/2004	US20040225120 Process for purifying a compound
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225117 Comprises oncogenic protein for use in identifying modulators for prevention and treatment of cell proliferative and inflammatory disorders
11/11/2004	US20040225116 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
11/11/2004	US20040225114 IGF-1 receptor interacting proteins
11/11/2004	US20040225113 Keratinocyte derived interferon
11/11/2004	US20040225112 Genes encoding single chain human leukocyte antigen E (HLA-E) proteins to prevent natural killer cell-mediated cytotoxicity
11/11/2004	US20040225108 Novel process for production of the somatostatin analog, octreotide
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004	US20040224909 For inhibiting proliferation of a human tumor cell
11/11/2004	US20040224894 Methods and use of motoneuronotrophic factor
11/11/2004	US20040224893 administering interleukin-1 antagonists; restenosis, atherosclerosis, vascular access dysfunction; anticholesterol, hypotensive agents
11/11/2004	US20040224891 Methods for the early diagnosis of ovarian cancer
11/11/2004	US20040224889 extracellular administration; antisense therapy

1 ... 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 ... 2916